No free lunches: balancing bleeding and efficacy with ticagrelor
- PMID: 22096089
- DOI: 10.1093/eurheartj/ehr424
No free lunches: balancing bleeding and efficacy with ticagrelor
Comment on
-
Bleeding complications with the P2Y12 receptor antagonists clopidogrel and ticagrelor in the PLATelet inhibition and patient Outcomes (PLATO) trial.Eur Heart J. 2011 Dec;32(23):2933-44. doi: 10.1093/eurheartj/ehr422. Epub 2011 Nov 16. Eur Heart J. 2011. PMID: 22090660 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
